| 标题 |
The safety and toxicity profile of SPL84, an inhaled antisense oligonucleotide for treatment of cystic fibrosis patients with the 3849 +10kb C->T mutation, supports a Phase 1/2 clinical study |
| 网址 | |
| DOI | |
| 其它 |
期刊:Expert Opinion on Drug Metabolism & Toxicology 作者:Lital Friedman; Ofra-Barchad Avitzur; Efrat Ozeri Galai; Nicolay Ferrari; Asaf Cohen; et al 出版日期:2023-10-03 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)